未登录Radiotherapy commissioning and tariff-how can we deliver advanced, innovative, and personalised radiotherapy?放射治疗验收与费用定价—我们如何实现先进的、创新的和个性化的放射治疗?
Powell Brown, Imogen; Hutton, Daniel; Thorp, Nicola; Thomson, James; MacKay, Ran; Hacker, Liesl; Ashmore, Lisa; Hayes, John; Archer, John; Rowbottom, Carl
分享
收藏Sustainable capital funding for modern and innovative radiotherapy services现代和创新放射治疗服务的可持续资本融资
Powell Brown, Imogen; Hutton, Daniel; Thorp, Nicola; Thomson, James; MacKay, Ran; Hacker, Liesl; Ashmore, Lisa; Hayes, John; Archer, John; Rowbottom, Carl
分享
收藏Considering late effects costs in radiotherapy fundingHutton, D.; Powell Brown, I.; Thorp, N.; Thomson, J.; MacKay, R.; Hacker, L.; Ashmore, L.; Hayes, J.; Archer, J.; Rowbottom, C. 考虑放疗资金中的晚期效应成本。Br. J. Radiol. 2025, 98, 2038–2040. [Google Scholar] [CrossRef]
Hutton, Daniel; Powell Brown, Imogen; Thorp, Nicola; Thomson, James; MacKay, Ran; Hacker, Liesl; Ashmore, Lisa; Hayes, John; Archer, John; Rowbottom, Carl
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Dose Intensified Hypofractionated IMRT With Synchronous Cetuximab for Intermediate-Stage Head and Neck Squamous Cell Carcinoma (HNSCC): Results From the Phase 1/2 INTENSE Trial
Thomson, D.; Ho, K.; Ashcroft, L.; Denton, K.; Mais, K.; Garcez, K.; Yap, B.; Lee, L.; Sykes, A.; Rowbottom, C.; Slevin, N.
分享
收藏
分享
收藏
分享
收藏